Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Imatinib/nilotinib

Various toxicities: case report

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Glaser D, Glaeser H, Mandery K, Borchert K, Jost K, Junghanss C, Leithaeuser M, Schmitt M, Freund M, Hilgendorf I.A case report: Association of polymorphisms in drug transporters and drug metabolizing enzymes with the response to imatinib treatment. Onkologie 34 (Suppl. 6): 267, Sep 2011. Available from: URL: http://dx.doi.org/10.1159/000333305 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Imatinib/nilotinib. React. Wkly. 1386, 22 (2012). https://doi.org/10.2165/00128415-201213860-00076

    Download citation

    Keywords

    • Stem Cell
    • Congenital Anomaly
    • Imatinib
    • Cell Transplantation
    • Stem Cell Transplantation